Laminar Pharmaceuticals, a biopharmaceutical company based at ParcBit in Palma and in Massachusetts, is preparing a clinical study to treat Covid-19. Pablo Escribá, professor of biology at the University of the Balearic Islands and founder of Laminar, says that the study could begin in a few months. It will be into molecules that inhibit fusion of the virus membrane.
Coronavirus
Palma company preparing clinical trials of Covid-19 inhibitor
Also in News
- Emergency declared on Ryanair flight bound for Palma from Dublin
- British tourists will be “tracked” while on holiday in Mallorca
- Mallorca ambassador Sir Bradley Wiggins has “lost” his Mallorca home
- Mallorca restaurants losing clients, tourists tighten their belts
- Mallorca hotelier - "I wouldn't go to a place where I perceived there to be animosity towards tourists"
No comments
To be able to write a comment, you have to be registered and logged in
Currently there are no comments.